Expression of EBNA3C is essential for the immortalization of B cells by EBV in vitro and, in co-operation with activated ras, EBNA3C has oncogenic activity in primary rodent ®broblasts. This suggested that this viral oncoprotein might disrupt the cyclin/CDK-pRb-E2F pathway, which regulates cell cycle progression at the restriction point (R-point) in G1 of the proliferation cycle. An assay was established in which transfected EBNA3C-positive cells could be sorted and simultaneously analysed for their distribution in the cell cycle. This revealed that in NIH3T3 ®broblasts compelled to arrest by serum-withdrawal, EBNA3C induces nuclear division that is often divorced from cytokinesis and so produces bi-and multinucleated cells. This was con®rmed using the ecdysone-inducible system for expression of EBNA3C in human U2OS cells and by microinjection of expression vectors into NIH3T3 and U2OS. Further analysis revealed that in the inducible system, EBNA3C expression inhibits the accumulation of p27 KIP1 but not the dephosphorylation of pRb. Experiments using the microtubule destabilizing drug nocodazole, showed that EBNA3C could abrogate the mitotic spindle checkpoint.
Introduction
In vitro, Epstein-Barr virus (EBV) very eciently induces the activation and continuous proliferation of a subset of resting human B cells. The resulting lymphoblastoid cell lines (LCLs), which have a phenotype resembling that of activated B-blasts, express only nine latent EBV proteins. There are six nuclear proteins [EBNAs 1, 2, 3A, 3B, 3C and Leader Protein (LP)] and three membrane-associated proteins (LMP1, 2A and 2B) (reviewed in Kie, 1996) . In vivo this ability of the virus to drive cell proliferation is important for the ampli®cation and spread of clones of cells capable of entering the memory B cell population and then sustaining a long-term persistent infection (Babcock et al., 1998) . In addition, EBV can be the causative agent in the benign lymphoproliferation infectious mononucleosis and is associated with at least four types of human tumour: Burkitt's lymphoma, nasopharyngeal carcinoma, Hodgkin's disease and immunoblastic or large cell lymphomas in the immunocompromized (reviewed in Rickinson and Kie, 1996) . EBNA3C has been shown by genetic analysis using recombinant virus to be one of the ®ve latent proteins which are necessary for the ecient immortalization of primary human B cells in vitro (Tomkinson et al., 1993; Kempkes et al., 1995) . We have also shown that, in co-operation with activated ras, EBNA3C has oncogenic activity in primary rat embryo ®broblasts (REFs) which is similar to that of papillomavirus E7 and adenovirus E1A (Parker et al., 1996) . Moreover, these experiments showed that EBNA3C could relieve suppression of REF transformation by the cyclin Ddependent kinase inhibitor (CDKI) p16 INK4A . These results indicated that EBNA3C might override normal signals for growth arrest at the restriction point (Rpoint) in G1 of the cell cycle when pRb is primarily active (reviewed in Weinberg, 1995) . EBNA3C can also act as a potent repressor of transcription when it is targeted to DNA as a fusion with the DNA binding domain of GAL4 Waltzer et al., 1996) . Moreover, the un-fused wild type protein can speci®cally repress reporter plasmids containing the EBV Cp latency-associated promoter. EBNA3C binds a transcriptional repression complex which includes histone deacetylase 1 (HDAC1) and is targeted to Cp by the cellular DNA binding protein RBP-JK (Radkov et al., 1997 (Radkov et al., , 1999 . Since Cp is the main promoter for EBNA mRNA initiation, it appears that EBNA3C contributes to a negative auto-regulatory control loop.
Here we show that in NIH3T3 cells, induced to arrest by serum-depletion, EBNA3C expression produces continued cell division. Moreover, detailed analysis showed that in these cells expressing high levels of EBNA3C, nuclear division was not always accompanied by cytokinesis and as a result, bi-and multinucleated cells accumulated. This ability to sustain cell cycle progression in quiescent cells was con®rmed using the ecdysone-inducible system for expression of EBNA3C in human U2OS cells and by microinjection experiments using both mouse and human cells. Further analysis of the cells which were inducible for EBNA3C, showed that induction of EBNA3C expression inhibits the accumulation of p27 KIP1 normally associated with the exit from the cell cycle induced by serum-withdrawal (Sherr and Roberts, 1995) . Experiments with the microtubule destabilizing drug nocodazole provide direct evidence that EBNA3C can also disrupt the regulation of mitosis.
Results

EBNA3C expressing NIH3T3 cells do not arrest in G1 after serum-depletion
Since EBNA3C can substitute for E7 and E1A and cooperate with (Ha-)ras in the transformation/immortalization of REFs (Parker et al., 1996) we established an assay in which the eect of EBNA3C on cell cycle progression could be determined directly. Cells were co-transfected with pSG5-EBNA3C and pSV2Neo DNA as described in the Materials and methods. Drug-resistant colonies were allowed to grow until they were macroscopically visible (10 ± 20 days) and then pooled. This delay eliminated the possibility of cellular stress induced by the transfection process in¯uencing the results. The cells were divided and then either cultured in medium containing a normal concentration of serum or incubated for up to 48 h with low serum in order to induce cell cycle arrest. After harvesting and ®xing, the cells were stained with mAb A10 for EBNA3C and then with propidium iodide for DNA. They were then analysed by¯ow cytometry. A typical experiment is shown in Figure 1a . As a standard procedure, total populations were electronically gated to remove doublets and very small debris and the EBNA3C-positive population was gated for high FITC compared to control transfected cells stained in a similar manner. In the NIH3T3 cells maintained in normal (in this experiment, 15%) serum, little dierence could be seen between the cell cycle pro®les of the EBNA3C-negative and -positive populations. However, when the serum concentration was reduced (to 0.5%) within 24 h it was clear that, while the negative population was beginning to arrest, the EBNA3C-expressing cells were still entering S phase and accumulating in the G2/M compartment. After 48 h this dierence between the two populations was even more pronounced. While only 10% of the negative cells were in the G2/M fraction, 32% of the EBNA3C-positive cells were found in this phase of the cell cycle. Furthermore, the total number of EBNA3C-positive cells relative to the negative cells had increased from 2 to 10% ± consistent with the continued proliferation of the EBNA3C-positive cells.
Nuclear division in cells expressing EBNA3C is not always accompanied by cytokinesis
In the initial comparison of EBNA3C-positive and -negative cells, the¯ow cytometric analysis of DNA content was restricted by the electronic gates applied to those cells with less than a 4 N DNA content; that is, normal diploid cells, those in S phase and those in G2 phase or mitosis. However, since EBNA3C expression appeared to induce a substantial accumulation of cells with a 4 N content when serum was withdrawn, the data were re-analysed to determine whether these cells continued to synthesize DNA and become polyploid. The ungated DNA pro®les of the EBNA3C-positive and -negative populations revealed that, even in 15% serum there were a signi®cant number of cells expressing EBNA3C which had a 44 N DNA content (30%) (Figure 1b) . When the serum concentration was reduced, the non-expressing cells produced a pro®le that was consistent with growth arrest and only 7% of the cells had a 44 N DNA content. In contrast the number of EBNA3C-positive cells with a DNA content 44 N had increased to 52% and distinct peaks corresponding to 6 N and 8 N could be seen. This apparent increase in ploidy in the serum-starved cells could result from endoreduplication (re-replication) where cells in G2 re-enter S phase prior to mitosis. Alternatively, these NIH3T3 cells could be completing mitosis but failing to undergo cytokinesis before initiating the next round of nuclear division and in this case multinucleated cells can be generated. Microscopical examination of multiple cultures of these transfected NIH3T3 grown in low serum commonly showed cells containing anything from 1 ± 7 nuclei, consistent with nuclear division occurring in Regulated expression of EBNA3C can induce cell cycle progression in serum-deprived U2OS cells
The above results suggested that EBNA3C expression was associated with cell cycle progression and sustained nuclear division in serum-depleted NIH3T3. However, these cells had been drug-selected for 2 ± 3 weeks and we previously showed that continuous high level expression of EBNA3C can be toxic in many cell types (our unpublished data). Therefore one could not rule out the possibility that an unusual sub-population of cells, which were able to tolerate EBNA3C, had been selected ± albeit in a very short time. In order to avoid this problem, U2OS cells which express EBNA3C regulated by Muristerone A were established. U2OS were considered suitable for these experiments since, although they are tumour derived, they retain normal levels of functional pRb, p53 and various CDKIs and undergo growth arrest in response to serum withdrawal.
In none of the clones analysed could 100% of the cells be induced to express EBNA3C up to the level detectable by immuno¯uorescence. In individual clones the percentage of cells which could be induced ranged from 1 to about 50%. Clone-26 was chosen for detailed analysis because after the addition of Muristerone A for *20 h, approximately 50% of the cells expressed EBNA3C at a level readily detectable by immunouorescence staining and also¯ow cytometry ( Figures  2 and 3a) . In 10% serum the U2OS clones behaved like the NIH3T3, that is, there was little or no dierence between EBNA3C-expressing and control cell cycle pro®les (data not shown). However, multiple experiments demonstrated that the cells expressing the highest level of EBNA3C after induction clearly continued to cycle in 0.1% serum and showed that most of the cells were distributed in S phase and G2/M even after 24 h in the serum depleted medium ( Figure  3a ). In contrast, non-expressing clone-5 cells (a control transfected with the empty vector) began to arrest after 24 h in 0.1% serum relative to the EBNA3C-positive cells. Although there was a signi®cant dierence between the pro®les of the EBNA3C-positive and -negative population of clone-26, in 0.1% serum, the apparently negative population does not arrest as convincingly as the clone-5 cells. This is probably because the level of EBNA3C induction in individual cells is highly variable and the`negative' population actually includes numerous cells expressing EBNA3C at a level below the detection threshold of the¯ow cytometer but high enough to alter the behaviour of the cell.
EBNA3C expression prevents the accumulation of p27 KIP1 but does not prevent the dephosphorylation of pRb in serum-deprived U2OS cells A particularly striking molecular change which occurs when normal cells are deprived of serum mitogens, is a rapid increase in the level of p27 KIP1 protein as cells cease to proliferate. This is generally considered to be a hallmark of (normal) cells exiting from the cell cycle (Sherr and Roberts, 1995) . The increase in p27, which is mediated by translational and post-translational mechanisms (Hengst and Reed, 1996; Pagano et al., 1995) , inhibits cyclin-CDK complexes which are required for the phosphorylation of pRb, and results in cells arresting in G1 and exiting from the cell cycle. The expression of p27 KIP1 was therefore investigated in this inducible system. U2OS clones-5 and -26 were incubated in 0.1% serum for *24 h (with or without preincubation with Muristerone A), protein extracts were made and immunoblotted for p27 KIP1 or pRb. As expected, the level of p27 KIP1 protein in extracts from control clone-5 cells substantially increased when the cells were incubated for 24 h in 0.1% serum but Muristerone A had no eect ( Figure 3b ). When clone-26 cells, in which high level expression of EBNA3C had not been induced, were transferred to low serum, there was a modest but signi®cant increase in the level of p27 (Figure 3b , ®rst two tracks, bottom panel). In dramatic contrast, when Muristerone-A was added and EBNA3C expression was induced, the level of p27 KIP1 expressed was reduced to a barely detectable level in low serum.
Another Western blot of the same extracts probed for pRb showed that as p27 KIP1 accumulated in the control clone-5 cells there was the expected concomitant dephosphorylation of pRb. Surprisingly, even in the clone-26 cells which expressed high levels of EBNA3C and which failed to arrest in low serum, pRb also became dephosphorylated in 0.1% serum. This cell cycle progression in the presence of functional (dephosphorylated) pRb suggests that pRb-containing repression complexes could be the target for EBNA3C. In both Western blots, each track contained 40 mg of total protein as determined by a standard biochemical assay. Equal loading was also con®rmed on a coomassie blue stained gel (data not shown).
Since clone-26 appeared to be heterogenous for EBNA3C expression after induction, it was sub-cloned by limiting dilution and ring-cloning. Sub-clones were analysed by immuno¯uorescence (data not shown). As with the parental clone none could be induced to more than 50% EBNA3C-positive and most were only a few per cent positive by IF (data not shown). The precise reason for this is not known, but we suspect that KIP1 levels were not signi®cantly aected by low serum. The behaviour of both types of clone was consistent with them being unable to exit from the cell cycle. Western blotting with an anti-EBNA3C mAb showed that in all the subclones examined, a detectable level of EBNA3C was expressed, even in the absence of induction by Muristerone A. Although the degree of induction was substantial in every case, all the sub-clones examined were`leaky' for expression of the ectopic gene ( Figure  4 and data not shown). This probably accounts for the lack of p27 KIP1 accumulation seen even in the absence of Muristerone A in some clones. The Western blot ®lters were also probed with a mAb to proliferating cell nuclear antigen (PCNA) and in all the extracts its level remained constant. Northern blot analysis showed no alteration in the levels of p27 KIP1 mRNA in response to changes in serum concentration or EBNA3C (data not shown).
EBNA3C expression can induce multi-nucleated cells
The initial experiments performed in NIH3T3 cells suggested that in addition to driving cell cycle progression in G1, sustained expression of EBNA3C in cells deprived of serum growth factors could induce polyploidy and multinucleated cells (Figure 1b and our unpublished data). Consistent with this observation, when human U2OS clone-26 cells were induced with Muristerone A to express high levels of EBNA3C while being cultured in 0.1% serum, the result was numerous bi-and multi-nucleated cells staining positive for EBNA3C (see for examples Figure 5a ). In order to test whether EBNA3C could produce such aberrant nuclear structures in a dierent experimental system, both NIH3T3 and U2OS cells were microinjected with EBNA3C expression vector (pSG5-EBNA3C) DNA. Examples of cells stained for EBNA3C expression are shown in Figure 5b . When the cells were maintained in 10% serum for the microinjections and then ®xed and stained about 20 h later, most of the injected cells showed nuclear¯uorescence corresponding to EB- . Cells were treated for 24 h with Muristerone A and then transferred to medium containing 0.1% serum and incubated for a further 24 h before harvesting. Analysis was performed as described in Figure 1 using the A.10 mAb to identify the population expressing high levels of EBNA3C. (b) Expression of p27 KIP1 and pRb in U2OS with inducible EBNA3C. Western blots of extracts from cells incubated with medium supplemented with the concentration of serum indicated. Muristerone A was added to the samples indicated 24 h before changing the serum. Cells were harvested 24 h after the serum change and proteins were extracted, their concentration was assayed and 40 mg was loaded in each track. The proteins were separated by SDS ± PAGE (7.5% for the pRb and 12.5% for p27 KIP1 ), transferred to nitrocellulose and probed with the appropriate mAb Figure 4 Regulation of p27 KIP1 in EBNA3C-expressing subclones of clone-26. Western blots of extracts from cells incubated with medium supplemented as indicated. Experiments were performed as described in the legend to Figure 3b and Materials and methods. Extracts were separated in a 7.5% gel for the EBNA3C and PCNA blots and a 12.5% gel for the p27 KIP1 EBNA3C induces multinucleated cells GA Parker et al NA3C. In contrast, if the cells were maintained in low serum (0.1 or 0.5%) for 24 h prior to injection, far fewer cells stained positive for EBNA3C. However, strikingly, many of these positive cells showed two nuclei and in one case (only 20 h after injection with pSG5-EBNA3C DNA) a U2OS cell was discovered with three EBNA3C-positive nuclei (Figure 5b , bottom right panel). The injected nucleus must have completed two mitotic divisions without intervening cytokinesis, in low serum, in less than 20 h and produced a polyploid cell.
It is currently unclear why fewer of the cells which were microinjected in low serum express EBNA3C, however, one possibility we are currently investigating is that aberrant mitosis may sometimes result in default apoptosis and the detachment of cells from the cover slip.
EBNA3C can overcome a mitotic spindle assembly checkpoint
The data presented above suggested that EBNA3C expression not only deregulates a checkpoint in G1 of the cell cycle, but that it might also aect the regulation of checkpoints later in the cell cycle. Since in three dierent experimental systems (transfected NIH3T3, inducible expression in U2OS and microinjection of both NIH3T3 and U2OS), EB-NA3C was associated with aberrant mitosis, this led us to test whether the mitotic spindle assembly checkpoint was aected by EBNA3C expression. Normally a checkpoint monitors the proper assembly of the mitotic spindle, thus ensuring the integrity of the cellular apparatus which pulls chromatids apart during anaphase of mitosis (reviewed in Orr-Weaver and Weinberg, 1998; Morgan, 1999) . Although this checkpoint is probably involved in the normal timing of mitosis, it can also be triggered by damage to the spindle (Taylor and McKeon, 1997). Thus inhibition of mitotic spindle assembly by microtubule poisoning drugs such as nocodazole leads to cell cycle arrest in metaphase of mitosis (Kung et al., 1990) .
In a series of experiments the control U2OS cells and cells induced to express EBNA3C were treated with nocodazole (100 ng/ml) for 24 h and then stained with DAPI and analysed by microscopy. A representative experiment using the unmodi®ed parental U2OS cells, clone-5, and the two sub-clones of clone-26 described above (26.1 and 26.2) is shown in Figure 6 . The unmodi®ed U2OS and clone-5 cells had a very high mitotic index (80 ± 90%) after 24 h incubation with nocodazole (100 ng/ml). This was revealed in the non-adherent (NA) population of cells which were arrested in metaphase and produced the chromosomè spreads' characteristic of mitotic checkpoint activation ( Figure 6 , upper middle panels). Very few cells remained adherent. Similar analysis of both the EBNA3C-expressing sub-clones (which had been induced with Muristerone A) showed that these cells had a very low mitotic index (410%) after treatment with nocodazole ( Figure 6 , lower middle panels). Consistent with the spindle checkpoint being suppressed, most of the cells (490%) did not arrest in metaphase but were attached to the substrate at the end of the experiment. Many of these cells contained enlarged or morphologically aberrant interphase nuclei that exhibited the features of micro-nucleation produced when mitosis is completed with a damaged spindle and chromosome segregation is not symmetrical ( Figure 6 , lower right panels). These data are all consistent with EBNA3C disrupting the spindle assembly checkpoint. (Figure 7a ). Cell cycle analyses of clone-10 early after the colony was expanded (5passage 10) revealed pro®les resembling the NIH3T3 cells expressing comparable levels of EBNA3C (compare Figures  7b with 1b) . That is, in medium containing 10% EBNA3C-expressing clone-26.1 and clone-26.2 (lower six panels) were incubated with Muristerone A for 24 h then treated exactly as the U2OS and clone 5 cells. Aberrant nuclei in the adherent cells, after treatment with nocodazole, are indicated by white arrows (lower right panels). All the cells were visualised with DAPI stain as described in Materials and methods serum the cells had a similar pro®le to EBNA3C-negative normal diploid cells but with slightly more cells in G2/M and a minor but signi®cant 44 N population. When these cells were incubated in medium with 0.1% serum the proportion of cells with 4 N DNA content signi®cantly increased and moreover peaks corresponding to 6 N and 8 N appeared. This was very similar to the EBNA3C-positive population of NIH3T3 cells in 0.5% serum ( Figure  1b) . Examination by phase-contrast microscopy of the cells incubated at the reduced serum concentration for 72 h showed that up to 30% of the cells contain two or more nuclei (data not shown) providing further con®rmation that karyokinesis can become divorced from cytokinesis in EBNA3C-expressing cells. We assume this large number of bi-nucleated cells accounts for the exaggerated 4 N peak seen in the FACs pro®le of their DNA content (Figure 7b ).
However, when the cell cycle pro®le of clone-10 was examined after a further 6 ± 10 passages (4p15) in 10% serum, the majority of the cells had a 4 N ± 8 N DNA content, consistent with the clone becoming tetraploid. Further analysis of the DNA content of these cells passaged more than 20 times revealed clone-10 had stabilized as a tetraploid line (Figure 7b , bottom panel) with cells containing a single large nucleus (data not shown). By this stage diploid (2 N) cells had almost disappeared from the population and EBNA3C was undetectable by¯ow cytometry or Western blotting (data not shown). The behaviour of this clone was consistent with the hypothesis that high level expression of EBNA3C can cause nuclear division in the absence of cytokinesis, produce multinucleated cells and result in unstable ploidy. It may also explain the toxicity associated with sustained EBNA3C expression. 
Discussion
In this study we have shown that the EBV encoded oncoprotein EBNA3C has the remarkable capacity to permit complete nuclear division even when growth inhibitory signals have been activated. We also provide good evidence that this involves the disruption of at least two cell cycle checkpoints. Using three independent experimental systems (transiently transfected mouse NIH3T3 cells, human U2OS cells carrying an inducible EBNA3C gene and microinjected NIH3T3 and U2OS) we have demonstrated that EBNA3C overcomes the restriction checkpoint that causes cells to arrest in G1 of the cell cycle in reduced serum. This failure of the EBNA3C-expressing cells to respond to normal anti-proliferative signals is consistent with the demonstration that p27 KIP1 in these cells does not accumulate when mitogens are withdrawn. The level of p27 KIP1 is considered to play a critical role in determining the timing of restriction point transition (Coats et al., 1996; Sherr and Roberts, 1995) so the idea that EBNA3C may speci®cally target this CDKI is rather attractive. However, although EBNA3C can act as a transcriptional repressor we have found no evidence that it in¯uences p27 KIP1 gene expression and so far we have been unable to ®nd any evidence of a direct interaction between the two proteins (our unpublished data). Although the reduction in p27 KIP1 represents a robust phenotype, at present we suspect that its deregulation is an indirect consequence of EBNA3C preventing exit from the cell cycle by some alternative mechanism. The dissociation of hypophosphorylated pRb from growth arrest is consistent with this hypothesis. EBNA3C could be directly inactivating the pRb complex and the relatively low levels of p27 KIP1 seen in the Western blots might merely re¯ect the number of cells that remain actively cycling. Since EBNA3C can bind to both HDAC1 and pRb (at least in vitro), the repression complex which includes E2F, pRb and histone deacetylase (reviewed in De Pinho, 1998 ) is a good candidate as the cellular target for EBNA3C in R-point deregulation. However, the precise functional signi®cance of these interactions will require a detailed biochemical and genetic analysis.
Further questions raised by this study concern the operation of cellular control mechanisms that act postG1. It was obvious from several dierent experiments that EBNA3C expression was associated with progression through both S and G2 phases and the completion of mitosis. However, normal cytokinesis did not always occur and in both mouse and human cells this resulted in the appearance of bi and multinucleated cells. Again this was seen in three independent assays. The phenotype was both novel and unexpected since it suggested that EBNA3C might disrupt not only G1 control but also a G2/M checkpoint.
In order to investigate whether EBNA3C has any eect on the spindle assembly checkpoint, a series of experiments were carried out using the microtubule destabilizing drug nocodazole. In normal cells nocodazole prevents the formation of the mitotic spindle and this activates a checkpoint in metaphase. In the two EBNA3C expressing clones this checkpoint was not activated, the cells appeared to complete mitosis and in many instances produced aberrant interphase nuclei.
These data are consistent with EBNA3C targeting some regulatory component of a mitotic checkpoint. In yeast Bub, Mad and Mps1 proteins monitor the interaction between chromosomes and the mitotic spindle. They respond to improper assembly of the spindle by blocking anaphase through inhibition of Cdc20 that would normally activate the anaphasepromoting complex, APC. The APC functions as a ubiquitin ligase in the destruction of mitotic cyclins A and B and anaphase inhibitors. Mammalian BUB and MAD proteins associate with kinetochores and if kinetochores fail to attach to microtubules, the BUB and MAD proteins remain bound and arrest the cell in metaphase by delaying the activation of APC. This regulation requires the binding of at least one MAD protein (MAD2) to the mammalian Cdc20 (reviewed in Orr-Weaver and Weinberg, 1998; Morgan, 1999) . EBNA3C could be acting anywhere in this complex regulatory network. It may act like HTLV1 Tax (Jin et al, 1998) and override the action of one or more inhibitory proteins (e.g. MADs or BUBs); alternatively, it could activate Cdc20 or APC or perhaps modify the action of a mitotic cyclin.
In summary, this report shows that in mouse and human cells, overexpression of EBNA3C can profoundly disrupt the cell cycle regulatory machinery (probably by acting on multiple checkpoints). In cells lacking mitogenic signals from the external medium, EBNA3C can provide internal signals that allow the nucleus to complete the cell cycle. However, EBNA3C cannot compensate for the concomitant failure to activate the signalling pathway that leads to cytokinesis. The net result is karyokinesis in the absence of cytokinesis leading to multiple nuclei in a single cell. Although we currently know little of the biochemistry involved, it should now be possible to subject EBNA3C to rational genetic analysis and to design experiments that identify molecular targets. This system may also be useful for the study of pathways involved in the regulation of mitosis and cytokinesis.
Materials and methods
Cell culture
Mouse NIH3T3 ®broblasts and human osteosarcoma cells U2OS (pRb-and p53-positive) (Shimizu et al., 1994) were maintained in DMEM supplemented with either 10 or 15% fetal calf serum (depending on the batch of serum) unless otherwise stated. Stable transfected sub-lines were maintained in a similar manner but with the addition of the appropriate drug selection.
Transfections and cell lines
Plasmids were introduced into NIH3T3 ®broblasts by calcium phosphate-mediated gene transfection as previously described (Crook et al., 1998) . In each transfection 10 mg of pSG5-EBNA3C plasmid DNA (Radkov et al., 1997) were mixed with 1 mg pSV2neo DNA. Forty-eight hours after transfection, cultures were divided and the medium was changed and colonies selected by growth in 1 mg/ml G418 (Gibco/BRL). As colonies began to merge on the dish (after 2 ± 3 weeks), cells were pooled for analysis.
The clones of U2OS expressing Muristerone A inducible EBNA3C were established essentially according to the suppliers instructions (`The Ecdysone System', Invitrogen).
Initially clones of U2OS constitutively expressing the heterodimeric ecdysone receptor of Drosophila were established by calcium phosphate-mediated gene transfection of pVgRXR plasmid DNA and selection with 1 mg/ml zeocin (Invitrogen). Clones were picked and screened for receptor expression. A suitable receptor-positive clone (U2OSpX5) was subsequently transfected with linearized pInd or pInd-EBNA3C plasmid DNA and selected with 1 mg/ml G418 and 300 mg/ml zeocin. Drug resistant colonies were ring-cloned, propagated as cell lines and where appropriate tested for inducible EBNA3C expression by IF and Western blotting. In the low serum experiments, where appropriate, cells were induced for 20 h with 1 mM Muristerone A (Invitrogen) before changing the serum concentration. Cells were induced with Muristerone A in a similar manner, prior to the addition of nocodazole (see below).
Flow cytometry
Total cells were harvested, ®xed in methanol at 7208C and re-hydrated in cold PBS. In some cases cells were stained with mAb E3C.A10 (see Radkov et al., 1997) by re-suspending in hybridoma supernatant. After incubating for 30 ± 60 min at room temperature, cells were washed twice in PBS and incubated with goat anti-mouse FITC-conjugated antibody (Dako) for 30 ± 60 min. Following further washing, cells were treated with 8 mg/ml RNAase A and stained with 18 mg/ml propidium iodide (PI) for at least 1 h and then analysed bȳ ow cytometry (Becton Dickinson, FACSort). Total populations were initially gated to remove doublets and very small debris and where appropriate the EBNA3C-positive population was gated for high FITC compared to control transfected cells stained in a similar manner. Where necessary the gates on FL2A were adjusted to include all cells with a greater than 4N DNA content. In order to eliminate cell aggregates all samples were passed several times through a 19-gauge syringe needle prior to FACs analysis.
Immunofluorescence and Western blot analysis
Cells on 35 mm dishes were washed in PBS and ®xed in methanol : acetone (50 : 50 v/v) at 7208C. After re-hydrating in PBS with 20% normal rabbit serum they were incubated with mAb E3C.A10 for 1 h. Following washing, FITCconjugated rabbit anti-mouse Ig (Dako) was applied for a further hour. After extensive washing then mounting the cells were visualized by microscopy and photographed.
Western blots were performed as described previously (Parker et al., 1996; Radkov et al., 1997) . MAb E3C.A10 was used to detect EBNA3C, mAb G3-349 (Pharmingen) for pRb and mAb 53G8.5 for p27 (Fredersdorf et al., 1997) . The anti-PCNA mAb used was in hybridoma supernatant (PC-10) provided by L Fallis and X Lu (LICR).
Microinjections
Cells were seeded on glass coverslips at a density of 4610 4 / coverslip. Twenty-four hours later the medium and, where appropriate the serum concentration, were changed. After a further 24 h, pSG5-EBNA3C DNA was microinjected into the nucleus of the adherent cells. Generally about 20 ± 30 cells per ®eld were injected. The cells were then incubated for a further 18 ± 20 h at 378C, washed twice with sterile PBS, ®xed for 10 min with methanol/acetone pre-cooled to 7208C, then air-dried. The cells were then immuno-stained for EBNA3C expression as described above.
Nocodazole experiments
Cells were seeded at 1610 5 /35 mm dish and Muristerone A was added to a give a ®nal concentration of 1 mM. After 20 ± 24 h Nocodazole (Sigma) was added to give a ®nal concentration of 100 ng/ml. Approximately 24 h later, the cells were washed twice with PBS. Care was taken to ensure all the loosely adherent metaphase-arrested cells were collected in addition to the normal adherent cells. These non-adherent cells were prepared for staining by cytospinning onto microscope slides. For DAPI staining of chromosomes and nuclei, all the cells were ®xed in 4% paraformaldehyde/PBS then stained for 10 min in DAPI (0.001% in PBS with 0.6% NP-40). After two washes in PBS and air-drying the cells were mounted in 10% glycerol in PBS. For¯ow cytometry the cells were treated as described above.
